Oncologic emergencies: recognition and initial management

ML Higdon, CJ Atkinson, KV Lawrence - American family physician, 2018 - aafp.org
Most oncologic emergencies can be classified as metabolic, hematologic, structural, or
treatment related. Tumor lysis syndrome is a metabolic emergency that presents as severe …

The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy

JAEM Zecha, JE Raber-Durlacher, AMGA Laheij… - Supportive Care in …, 2019 - Springer
Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during
cancer therapy-induced neutropenia. FN may herald life-threatening infectious …

White blood cell counting on smartphone paper electrochemical sensor

X Wang, G Lin, G Cui, X Zhou, GL Liu - Biosensors and Bioelectronics, 2017 - Elsevier
White blood cell (WBC) analysis provides rich information in rapid diagnosis of acute
bacterial and viral infections as well as chronic disease management. For patients with …

The potential contribution of dental foci and oral mucositis to febrile neutropenia in patients treated with myelosuppressive chemotherapy for solid tumors and …

JAEM Zecha, JE Raber-Durlacher… - Frontiers in oral …, 2022 - frontiersin.org
Introduction Febrile neutropenia (FN) is a potential life-threatening complication of
myelosuppressive chemotherapy, particularly when induced by infection. There is evidence …

Non-chemotherapy drug-induced neutropenia-an update

E Andrès, R Mourot-Cottet - Expert Opinion on Drug Safety, 2017 - Taylor & Francis
Introduction: To date, non-chemotherapy drug-induced severe neutropenia (neutrophil count
of≤ 0.5 x 109/L) also called idiosyncratic drug-induced agranulocytosis is little discussed in …

Research progress on the premature ovarian failure caused by cisplatin therapy

Z Li, H Qi, Z Li, Y Bao, K Yang, Q Min - Frontiers in Oncology, 2023 - frontiersin.org
Cisplatin is a common anticancer drug able to kill tumor cells, but it causes adverse
reactions in the kidney, digestive tract, and other systems. The antitumor effects of cisplatin …

Therapeutic drug monitoring of amikacin in neutropenic oncology patients

M Aquino, M Tinoco, J Bicker, A Falcão, M Rocha… - Antibiotics, 2023 - mdpi.com
Amikacin is the antibiotic of choice for the treatment of Gram-negative infections, namely,
those in neutropenic oncology patients. No populational pharmacokinetic studies are …

Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: a meta-analysis of the contributions of specific plants

M Chen, BH May, IW Zhou, DM Sze, CC Xue… - Critical reviews in …, 2016 - Elsevier
This review assessed the effects on chemotherapy induced neutropenia (CIN) of combining
oxaliplatin regimens with traditional plant-based medicines (TMs) in the management of …

Early subcutaneous drainage of skin and soft tissue infections in patients with febrile neutropenia: a new treatment option

S Perez, N Assaf, R Sinna - Annales de Chirurgie Plastique Esthétique, 2021 - Elsevier
Objectives Patients with febrile neutropenia presenting a cutaneous portal of entry for an
infectious agent are at high risk of death (19-32%). If medical management is well codified …

Evaluation der prognostischen Aussagefähigkeit von APACHE II, SAPS II und SOFA Scores bei hämatologisch-onkologischen PatientInnen in Neutropenie

MC Edner - 2023 - kups.ub.uni-koeln.de
Im Zuge der weltweit steigenden Fallzahlen für Krebsneuerkrankungen und des
fortschreitenden demographischen Wandels benötigen immer mehr kritisch kranke …